Amanote Research
Register
Sign In
Treatment With Interferon Beta-1a in Brazil Is Associated With Fewer Hospitalizations Due to Relapse, Better Adherence and a Better Response Compared to Other Platform Therapies
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.234
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
P Serafini
J Pike
E Jones
M Machado
Publisher
Elsevier BV
Related search
Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Better Antidepressant Prescribing Is Associated With Fewer Suicides
BMJ
Chronic Motor Neuropathies: Response to Interferon-Beta 1a After Failure of Conventional Therapies
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Attenuated Beta Endorphin Response to Acute Stress Is Associated With Smoking Relapse
Pharmacology Biochemistry and Behavior
Pharmacology
Biochemistry
Clinical Biochemistry
Behavioral Neuroscience
Toxicology
Biological Psychiatry
Better Patients’ Treatment Experiences Are Associated With Better Postoperative Results in Dupuytren’s Disease
Journal of Hand Surgery: European Volume
Surgery
Treosulfan Based Conditioning Regimen Is Associated With Better Overall Survival Compared to Busulfan Based Regimens in Older Children With Thalassaemia Major
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Late Best Response to Cardiac Resynchronization Therapy Is Associated With Better Survival of Patients With Congestive Heart Failure
Current Research Cardiology
Corrigendum: The Busier the Better: Greater Busyness Is Associated With Better Cognition
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Is It Better to Love Better Things?
